Dr. Gupta has followed scientific research currently being conducted… Researchers are finding that users of CBD are getting relief, they actually have scanned the brain and have found the evidence as to how and why this happens to effect the brain.
RELATED: Dr Sanjay Gupta of CNN endorses CBD-Oil… Many do not know CBD from Hemp is legally available? Read the incredible development in this story
CBD-Oil Special 1
CBD-OIL Special 2
CBD-OIL Special 3
A healthy appetite is vital to a healthy body, especially when the body is healing. Some illnesses decrease the appetite to the point of preventing the body from healing itself. CBD stimulates appetite, according to the National Cancer Institute. In the human body, CBDs bind to cannabinoid receptors in the body. Scientists believe these receptors play an important role in regulating feeding behavior. CBDs stimulate appetite when they dock onto these receptors.
CBD also eases nausea and vomiting. This is especially helpful for individuals enduring chemotherapy and other treatments for serious diseases.
CBDs bind to CB1 receptors in the body to relieve pain. CBD also has an anti-inflammatory effect that reduces swelling.
CBD may alleviate severe social anxiety. Generalized Social Anxiety Disorder, or SAD, is one of the most common forms of anxiety disorders that impair quality of life. Some consumers complain of increased social anxiety after marijuana use but this may be due to low levels of CBD proportionate to the higher levels of THC.
In a 2011 study, scientists wanted to study the effects of CBD on people with SAD. The scientists selected 24 people with this condition who had never received treatment for SAD then divided participants into two groups. One group received 600 mg of CBD while the control group received a placebo. The scientists then asked study participants to take part in a simulated public speaking test while researchers measured blood pressure, heart rate and other measurements of physiological and psychological stress.
The CBD group showed significantly reduced anxiety, cognitive impairment and discomfort in their speech performance. In comparison, those in the placebo group presented higher anxiety, cognitive impairment and discomfort.
According to the National Institute of Mental Health, approximately 15 million adults in the United States have social phobia and about 6.8 million have a generalized anxiety disorder. Traditional treatment usually involves counseling and medications. Treatment with CBD may be better than anti-depressants because it acts quickly and does not cause side effects or withdrawal symptoms.
The National Cancer Institute details several studies into the anti-tumor effects of CBD. One study in mice and rats suggest CBDs “may have a protective effect against the development of certain types of tumors.” CBDs may do this by inducing tumor cell death, inhibiting cancer cell growth, and by controlling and inhibiting the spread of cancer cells.
One study by California Pacific Medical Center suggests CBD “turns off” the gene involved in the spread of breast cancer. These scientists found CBD-inhibits ID-1, an action that prevents cancer cells from traveling long distances to distant tissues.
CBD relieves psychotic symptoms associated with schizophrenia, according to research by University of Cologne in Germany. Schizophrenia affects about 1.1 percent of the population, or approximately 2.4 million adults in the United States.
CBD continues to surprise medical researchers with the variety of common health benefits it provides. An increasing number of scientists, physicians and consumers are learning about these health benefits and incorporating CBD into a healthy lifestyle plan.
The sale, production and distribution of CBD oils/products derived from imported raw material industrial hemp is not in violation of the Controlled Substances Act (CSA). CBD, and even THC, when in industrial hemp oil, are legal. The importation of industrial hemp is lawful, as exempt parts of the “marijuana” plant such as industrial hemp fiber, stalk, seed and oils can be lawfully imported into the United States and these portions of an industrial hemp plant may enter into United States commerce. The DEA cannot regulate naturally-occurring CBD not contained within or derived from “marijuana,” i.e., non-psychoactive hemp products, because non-psychoactive hemp from the stalks and fibers of industrial hemp are not included in Schedule I. The DEA has no authority to regulate drugs that are not scheduled/defined.